Cellebrite DI Ltd. (NASDAQ:CLBT) Sees Large Increase in Short Interest

Cellebrite DI Ltd. (NASDAQ:CLBTGet Free Report) was the recipient of a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 1,170,000 shares, an increase of 13.6% from the December 15th total of 1,030,000 shares. Based on an average daily volume of 1,310,000 shares, the short-interest ratio is presently 0.9 days. Approximately 1.4% of the shares of the company are sold short.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on CLBT shares. JPMorgan Chase & Co. increased their price objective on shares of Cellebrite DI from $22.00 to $24.00 and gave the stock an “overweight” rating in a research note on Monday, December 16th. Craig Hallum upped their target price on Cellebrite DI from $23.00 to $24.00 and gave the company a “buy” rating in a report on Thursday, November 7th. Needham & Company LLC raised their price target on Cellebrite DI from $17.00 to $21.00 and gave the stock a “buy” rating in a report on Thursday, November 7th. Finally, TD Cowen upped their price objective on Cellebrite DI from $20.00 to $23.00 and gave the stock a “buy” rating in a research note on Monday, September 23rd. Eight equities research analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $20.57.

View Our Latest Stock Analysis on CLBT

Institutional Investors Weigh In On Cellebrite DI

Hedge funds and other institutional investors have recently modified their holdings of the stock. Renaissance Technologies LLC increased its stake in shares of Cellebrite DI by 22.1% during the second quarter. Renaissance Technologies LLC now owns 1,183,700 shares of the company’s stock valued at $14,145,000 after acquiring an additional 214,600 shares during the period. Hsbc Holdings PLC increased its position in shares of Cellebrite DI by 44.7% during the 2nd quarter. Hsbc Holdings PLC now owns 238,002 shares of the company’s stock valued at $2,866,000 after purchasing an additional 73,533 shares during the period. Public Employees Retirement Association of Colorado acquired a new position in shares of Cellebrite DI during the 2nd quarter valued at $71,000. Sei Investments Co. raised its stake in shares of Cellebrite DI by 16.9% in the 2nd quarter. Sei Investments Co. now owns 141,644 shares of the company’s stock worth $1,693,000 after buying an additional 20,478 shares in the last quarter. Finally, Magnetar Financial LLC acquired a new stake in shares of Cellebrite DI in the second quarter valued at $143,000. 45.88% of the stock is currently owned by institutional investors.

Cellebrite DI Stock Down 0.9 %

CLBT opened at $22.78 on Monday. The business’s 50 day moving average is $20.76 and its 200-day moving average is $17.64. Cellebrite DI has a twelve month low of $8.23 and a twelve month high of $23.50.

Cellebrite DI (NASDAQ:CLBTGet Free Report) last posted its earnings results on Wednesday, November 6th. The company reported $0.14 EPS for the quarter, beating the consensus estimate of $0.09 by $0.05. Cellebrite DI had a positive return on equity of 122.59% and a negative net margin of 82.28%. The firm had revenue of $106.90 million for the quarter, compared to analysts’ expectations of $102.06 million. During the same period last year, the firm earned $0.09 EPS. The firm’s revenue was up 27.0% compared to the same quarter last year. As a group, equities research analysts forecast that Cellebrite DI will post 0.32 earnings per share for the current year.

About Cellebrite DI

(Get Free Report)

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.

Read More

Receive News & Ratings for Cellebrite DI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellebrite DI and related companies with MarketBeat.com's FREE daily email newsletter.